What are PMDA Standards, and what specific requirements do they include?
'PMDA Standards' is a collective term for the regulations and guidelines established by the Pharmaceuticals and Medical Devices Agency (PMDA) and the Ministry of Health, Labour and Welfare (MHLW). These standards are designed to ensure the Quality, Efficacy, and Safety of all pharmaceuticals and medical devices distributed within Japan.
Structural Understanding of the Regulatory Framework
PMDA Standards encompass a comprehensive set of rules covering the entire product lifecycle:
Standards for Manufacturing and Quality Control (GxP):
GMP (Good Manufacturing Practice): Standards for manufacturing control and quality control of products.
GQP (Good Quality Practice): Standards for quality control of the marketing authorization holder (MAH).
Benchmarks for Approval and Conformity Assessment:
The Japanese Pharmacopoeia (JP): The official compendium of standards for the properties and quality of drugs.
Essential Principles: Requirements regarding the safety and performance that medical devices must satisfy.
Individual Approval/Certification Standards: Specific review guidelines established for particular diseases or product categories.
Post-Marketing Safety Management
GVP (Good Vigilance Practice): Standards for post-marketing safety management to monitor adverse effects and ensure patient safety.
Professional Advice for Importers and Sourcing Partners
Conformity for the Japanese Market: When introducing overseas products to Japan, proof of conformity to these PMDA Standards is mandatory. In particular, the GMP Inspection of manufacturing facilities is a critical and rigorous step in the approval process.
Tracking the Latest Updates: Standards and guidelines are frequently updated to align with scientific progress. For the latest review policies regarding a specific product, we recommend checking the official PMDA website or consulting our regulatory specialists via Messages.